Earlier this week we wrote about the emerging trend of increasing state government involvement in the pharmaceutical industry. Today we learn about what the government in Brazil is doing. Of…
Like many of you, we are already scheduling meetings at the annual JP Morgan Healthcare Conference in San Francisco in January. This is an invitation-only event, but that doesn't stop…
Our good friends at Drug Delivery Technology have, as of January, changed the name of their publication to Drug Development and Delivery. Why is this significant? We think that drug…
Last week we wrote about the Russian government's desire to grow their national pharmaceutical infrastructure. Our reading of the situation is that the government will "suggest" that ex-Russia companies who…
Here is a sample of announcements from today alone regarding the pharmaceutical industry in India: First, UK-based Reckitt Benckiser is acquiring Paras Pharmaceuticals for $726 million. Paras makes a variety…
Earlier this week, Prime Minister Putin announced that the Russian government will invest nearly $4 billion to modernize the pharmaceutical industry in Russia. Of note: Putin said he wanted 90…
There is fascinating news today from Pfizer, who have decided to bypass the wholesalers in Australia and market directly to community pharmacies. To quote, "In order to develop stronger partnerships with…